Related Experiment Video
Updated: Apr 21, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Pediatric Acute Hematogenous Osteomyelitis
Matthew Street1, Rupesh Puna, Mark Huang
1*Starship Children's Hospital †Department of Medicine, University of Auckland, Auckland, New Zealand.
Insights
Acute hematogenous osteomyelitis (AHO) in New Zealand children shows decreasing incidence but persistent overrepresentation of Maori and Pacific Islanders. Staphylococcus aureus remains the primary pathogen with low MRSA rates, suggesting flucloxacillin is effective for empiric treatment.
Area of Science:
- Pediatric Orthopedics
- Infectious Diseases
- Epidemiology
Background:
- Osteomyelitis presents a significant challenge in New Zealand's pediatric population.
- This study examines acute hematogenous osteomyelitis (AHO) cases to identify trends and inform management.
Purpose of the Study:
- To analyze trends in pediatric AHO in Auckland over a 10-year period.
- To guide effective management strategies for AHO in the New Zealand context.
Main Methods:
- Retrospective review of clinical records from two Auckland pediatric orthopedic departments (1997-2008).
- Inclusion of 813 pediatric AHO cases.
- Level IV-retrospective case series.
Main Results:
- AHO incidence decreased over the decade (1:4000), with male predominance and overrepresentation of Maori and Pacific Islanders.
- Staphylococcus aureus was the most common pathogen (low MRSA incidence at 2%).
- Average antibiotic treatment was 44 days, 44% required surgery, yielding a 7% recurrence rate and 15% complication rate.
Conclusions:
- AHO incidence remains high in New Zealand, particularly among Maori and Pacific Islanders.
- Low MRSA rates support flucloxacillin as empiric treatment; S. aureus is the main pathogen.
- Low relapse rates may be linked to longer antibiotic courses, though this increases complication risk. Prompt diagnosis and tailored treatment are key to minimizing severe outcomes.
Background:
Osteomyelitis continues to be a significant problem among the New Zealand pediatric population. We present a large series of acute hematogenous osteomyelitis (AHO) cases, with the aim to identify any changing trends and guide successful management of the disease.
Methods:
A 10-year retrospective review was performed of clinical records of children with AHO at the 2 children's orthopaedic departments in the Auckland region. Cases were identified from Starship Children's Hospital between 1997 and 2007 and Middlemore's Kidz First Hospital between 1998 and 2008.
Results:
A total of 813 cases of pediatric AHO were identified. The incidence was 1:4000, which was decreasing over the 10-year period. There was a male predominance and New Zealand (NZ) Maori and Pacific Islanders were overrepresented. The diagnosis was made clinically in 27%, radiographically in 66%, and surgically in 7%. The most common pathogen was Staphylococcus aureus and the incidence of methicillin-resistant S. aureus was low (2%). The average length of antibiotic treatment was 44 days and 44% required surgery. This produced a recurrence rate of only 7% and a 15% treatment-related complication rate.
Conclusions:
In the New Zealand population, the incidence of AHO remains high with NZ Maori and Pacific Islanders overrepresented. The predominant pathogen remains S. aureus and our population has a very low incidence of methicillin-resistant S. aureus; flucloxacillin remains a good choice for empiric treatment in our population. Our rate of relapse and subsequent chronic osteomyelitis is low. This could be explained by traditionally longer antibiotic courses; however, this may also lead to increased treatment-related complications. Through prompt and accurate diagnosis with the aid of laboratory and radiologic tests and effective treatment with appropriate antibiotics (guided by local pathogen sensitivities) and surgical treatment when indicated, AHO can be well managed with minimal severe complications.
Level Of Evidence:
Level IV-retrospective case series.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
05:10Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
Published on: February 7, 2025
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis I: Introduction